Clinical Trial Update: Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.

View source ↗

Summary

This completed clinical trial evaluated using a liquid biopsy based on exosomal miRNA to stratify metastasis risk in intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: City of Hope Medical Center | Conditions: Intrahepatic Cholangiocarcinoma (Icc) | Status: COMPLETED